Sonendo Inc
OTC:SONX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (0.3), the stock would be worth $11.86 (3 493% upside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0 | $0.33 |
0%
|
| 3-Year Average | 0.3 | $11.86 |
+3 493%
|
| 5-Year Average | 0.4 | $15.79 |
+4 684%
|
| Industry Average | 1.7 | $64.75 |
+19 522%
|
| Country Average | 2.4 | $90.39 |
+27 292%
|
Forward P/S
Today’s price vs future revenue
| Today's Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
$153.9k
|
/ |
Jan 2025
$31.7m
|
= |
|
|
$153.9k
|
/ |
Dec 2025
$36.4m
|
= |
|
|
$153.9k
|
/ |
Dec 2026
$43.1m
|
= |
|
Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Sonendo Inc
OTC:SONX
|
141k USD | 0 | -0 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
165.7B USD | 16.5 | 58 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
163B USD | 3.6 | 26 | |
| US |
|
Stryker Corp
NYSE:SYK
|
122.9B USD | 4.9 | 37.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
105.1B USD | 3 | 22.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
86.7B USD | 4.2 | 24.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.8B USD | 7.6 | 43.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.8B EUR | 1.7 | 18.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.3B USD | 10.5 | 42.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
42.6B USD | 1.9 | 24.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
31.6B USD | 5.9 | 21.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.2 |
| Median | 2.4 |
| 70th Percentile | 4.1 |
| Max | 4 613 274.2 |
Other Multiples
Sonendo Inc
Glance View
Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. The company is headquartered in Laguna Hills, California and currently employs 219 full-time employees. The company went IPO on 2021-10-29. The firm has developed GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company is focused on leveraging the GentleWave System, a root canal therapy for late-stage tooth decay that employs a sterilized, single-use procedure instrument. In addition to its GentleWave console and single-use procedure instruments, it also offers single-use products, such as SoundSeal and the Company's Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown. Its EDTA is a liquid used during the GentleWave Procedure to help debride and disinfect the root canal system. The company also offers TDO practice management software.
